GlaxoSmithKline Trading Services Limited
25 products tracked · names used in filings: GlaxoSmithKline Trading Services Limited
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 22 Oct 2026🇪🇺 EU approval (EC decision)
Lynavoy (Linerixibat) approved in the EU
Marketing authorisation to GlaxoSmithKline Trading Services Limited; Orphan, Additional monitoring · source
Thu 23 Jul 2026🇪🇺 CHMP positive opinion
Lynavoy (Linerixibat): CHMP positive opinion
GlaxoSmithKline Trading Services Limited; Orphan, Additional monitoring · source
Thu 12 Feb 2026🇪🇺 EU approval (EC decision)
Exdensur (depemokimab) approved in the EU
Marketing authorisation to GlaxoSmithKline Trading Services Limited; Additional monitoring · source
Thu 11 Dec 2025🇪🇺 CHMP positive opinion
Exdensur (depemokimab): CHMP positive opinion
GlaxoSmithKline Trading Services Limited; Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Jesduvroq daprodustat | Application withdrawn | |
| 🇪🇺 | Lynavoy Linerixibat | Authorised | 2026-10-22 |
| 🇪🇺 | Exdensur depemokimab | Authorised | 2026-02-12 |
| 🇪🇺 | Blenrep belantamab mafodotin | Authorised | 2025-07-23 |
| 🇪🇺 | Omjjara momelotinib | Authorised | 2024-01-25 |
| 🇪🇺 | Xevudy sotrovimab | Withdrawn | 2021-12-17 |
| 🇪🇺 | Jemperli dostarlimab | Authorised | 2021-04-21 |
| 🇪🇺 | Blenrep belantamab mafodotin | Expired | 2020-08-25 |
| 🇪🇺 | Temybric Ellipta fluticasone furoate;umeclidinium;vilanterol | Lapsed | 2019-06-12 |
| 🇪🇺 | Dectova zanamivir | Authorised | 2019-04-26 |
| 🇪🇺 | Zejula niraparib | Authorised | 2017-11-16 |
| 🇪🇺 | Trelegy Ellipta fluticasone furoate;umeclidinium;vilanterol | Authorised | 2017-11-15 |
| 🇪🇺 | Elebrato Ellipta fluticasone furoate;umeclidinium;vilanterol | Authorised | 2017-11-15 |
| 🇪🇺 | Rolufta Ellipta (previously Rolufta) umeclidinium | Authorised | 2017-03-20 |
| 🇪🇺 | Nucala mepolizumab | Authorised | 2015-12-01 |
| 🇪🇺 | Laventair Ellipta (previously Laventair) umeclidinium bromide;vilanterol | Authorised | 2014-05-08 |
| 🇪🇺 | Anoro Ellipta (previously Anoro) umeclidinium bromide;vilanterol | Authorised | 2014-05-08 |
| 🇪🇺 | Revinty Ellipta fluticasone furoate;vilanterol | Authorised | 2014-05-02 |
| 🇪🇺 | Incruse Ellipta (previously Incruse) umeclidinium bromide | Authorised | 2014-04-28 |
| 🇪🇺 | Eperzan albiglutide | Withdrawn | 2014-03-20 |
| 🇪🇺 | Relvar Ellipta fluticasone furoate;vilanterol | Authorised | 2013-11-13 |
| 🇪🇺 | Volibris ambrisentan | Authorised | 2008-04-21 |
| 🇪🇺 | Avamys fluticasone furoate | Authorised | 2008-01-11 |
| 🇪🇺 | Zeffix lamivudine | Authorised | 1999-07-29 |
| 🇪🇺 | Integrilin eptifibatide | Withdrawn | 1999-07-01 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.